Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.

By Kyle E. Rusthoven, B. Kavanagh, S. Burri, Changhu Chen, H. Cardenes, M. Chidel, T. Pugh, M. Kane, L. Gaspar, T. Schefter. Journal of Clinical Oncology, 2009

956 citations recorded by the source corpus.

Subfields: Hepatology, Radiation, Surgery

View Paper: https://www.semanticscholar.org/paper/6ca0cbb8cd2426b9708cd82feb18f8d1adc1fd5d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. P. Iyengar
2. Z. Wardak
3. D. Gerber
4. V. Tumati
5. C. Ahn
6. H. Choy
7. N. Cheedella
8. J. Dowell

Citations in the corpus

• Consolidative Radiotherapy for Limited Metastatic Non–Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial (2018, methodology): “Multiple meta-analyses, single-institution observational studies, retrospectiveexperiences, and limitedsinglearm prospective trials suggest that local therapy in the limited metastatic disease state for NSCLC may augment survival.(17-27)Finally, a recent phase 2 randomized study(28) includingpatient”